Aurinia Pharmaceuticals Stock News

NEW YORK, Dec. 9, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for ENSC, SYTA, EVGO, AUPH, and HOFV. To see how InvestorsObserver''s proprietary scoring system rates these stocks, view the InvestorsObserver''s PriceWatch Alert by selecting the corresponding link.

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus FDA Committee Votes Against Recommending Approval Of Kidney Disease Drug Reata Pharmaceuticals, Inc.

Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) is up 4.8% to trade at $21.83, after a late-stage trial of the company's treatment for active lupus nephritis showed sustained efficacy and a favorable ris

VICTORIA, British Columbia--(BUSINESS WIRE)--Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) (Aurinia or the Company), a biopharmaceutical company committed to delivering therapeutics that change the course of autoimmune disease, today announced positive topline results from the AURORA 2 continuation study evaluating the long-term safety and tolerability of LUPKYNIS (voclosporin) for the treatment of adults with active lupus nephritis (LN), a serious complication in patients with systemic lupus ery

Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) has posted topline results from the AURORA 2 continuation study evaluating the long-term safety and tolerability of Lupkynis (voclosporin) for active lupu

The stock price of Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) increased by over 3% pre-market today. This is why it happened.

These eight stocks could rebound nicely over the next year and beyond.

Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) (TSE:AUP) has earned a consensus recommendation of Hold from the seven ratings firms that are covering the firm, MarketBeat.com reports. One research analyst has rated the stock with a sell recommendation, two have assigned a hold recommendation and four have issued a buy recommendation on the company. The average 1 year []

Aurinia Pharmaceuticals Inc. (AUPH) with the stream of -7.30% also noticed, India BrightSphere Investment Group Inc. (BSIG) encountered a rapid change of -9.50% in the last hour of Fridays trading The post Traders cant mares this Stock: Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH), BrightSphere Investment Group Inc. (NYSE:BSIG) appeared first on Stocks Equity .

Aurinia (AUPH) gains on rumors of a potential acquisition yet again. Reportedly, the company is being eyed by Novartis.

Renewed buyout speculation has investors piling into this biotech stock today.

Renewed buyout speculation has investors piling into this biotech stock today.

Novartis said Thursday it''s interested in "bolt-on" deals and investors zeroed in on Aurinia Pharmaceuticals, sending AUPH stock flying.

Vigilare Wealth Management purchased a new position in shares of Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) (TSE:AUP) in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund purchased 27,470 shares of the biotechnology companys stock, valued at approximately $608,000. A number of other institutional investors and []